Search results
Theseus (THRX) Up 57% in a Month on Strategic Restructuring Plan
Zacks via Yahoo Finance· 6 months agoTheseus (THRX) gains 57% in a month after announcing plans to conduct a process exploring strategic...
Theseus (THRX) Falls 72% on Decision to Discontinue GIST Study
Zacks via Yahoo Finance· 11 months agoTheseus (THRX) announces the discontinuation of enrollment in its phase I/II study of THE-630 in...
Theseus Pharmaceuticals (NASDAQ:THRX) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 8 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
What Makes Theseus Pharmaceuticals, Inc. (THRX) a New Buy Stock
Zacks via Yahoo Finance· 1 year agoTheseus Pharmaceuticals, Inc. (THRX) might move higher on growing optimism about its earnings...
Here's Why We're Not Too Worried About Theseus Pharmaceuticals' (NASDAQ:THRX) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth
Simply Wall St. via Yahoo Finance· 2 years agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
After more than 6O years, is Cuba even Cuba anymore? | Opinion
Miami Herald via AOL· 2 years agoTheseus was the mythical king and founder of Athens. Many myths surrounding Theseus and his journeys...
What is the 'ship of Theseus' thought experiment?
Live Science via Yahoo News· 1 year agoThe Greek writer Plutarch proposed this question: If a ship's planks are replaced over time due to wear and tear until none of the original pieces...
Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – March 22, 2023 – Today, Zacks Equity Research discusses CRISPR...
Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies
Benzinga via Yahoo Finance· 1 year agoNeedham has initiated coverage on Theseus Pharmaceuticals Inc (NASDAQ: THRX) with a Buy rating and a...